HRTX News and Press, Heron Therapeutics Inc. From 10/26/23

2023-10-26 14:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-07 12:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-09-08 19:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-08-30 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-08-14 18:48:08 ET Heron Therapeutics, Inc. (HRTX) Q2 2023 Earnings Conference Call August 14, 2023, 04:30 PM ET Company Participants Jeff Cohen - Executive Director, Assistant General Counsel and Assistant Secretary Craig Collard - Chief Executive Officer Ir...

2023-08-14 16:07:02 ET More on Heron Therapeutics Heron Therapeutics: Restructuring Brings About A New Dawn Heron Therapeutics: Look For Continued Limbo Stick Dancing - Extreme Investor Caution Merited Heron Therapeutics Q2 2023 Earnings Preview Heron Therape...

Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates PR Newswire Company is well capitalized after signing $50 million working capital credit facility and recent $30 million equity raise Favorable outcome at Markma...

2023-08-13 08:02:00 ET More on Cisco, Deere, etc. Compare metrics for CSCO to DE, HD, SNDL, TGT, WMT Walmart: The Bottom Could Fall Out If Inflation Levels Continue To Fall Home Depot: Long-Term Winner, With Room To Run Target estimates lowered at Barclays ah...

Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 PR Newswire SAN DIEGO , Aug. 7, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of ...

2023-07-28 15:57:50 ET Summary HRTX recently launched a fourth drug, Aponvie, with the first full quarter of product sales to come with Q2'23 earnings. An upcoming potential expansion of the Zynrelef label could see the drug used in twice as many surgeries, improving product sales...